Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Cancer Immunol Res. 2022 Jul 1;10(7):788-799. doi: 10.1158/2326-6066.CIR-21-0965.
We applied our computational algorithm TRUST4 to assemble immune receptor (T-cell receptor/B-cell receptor) repertoires from approximately 12,000 RNA sequencing samples from The Cancer Genome Atlas and seven immunotherapy studies. From over 35 million assembled complete complementary-determining region 3 sequences, we observed that the expression of CCL5 and MZB1 is the most positively correlated genes with T-cell clonal expansion and B-cell clonal expansion, respectively. We analyzed amino acid evolution during B-cell receptor somatic hypermutation and identified tyrosine as the preferred residue. We found that IgG1+IgG3 antibodies together with FcRn were associated with complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity or phagocytosis. In addition to B-cell infiltration, we discovered that B-cell clonal expansion and IgG1+IgG3 antibodies are also correlated with better patient outcomes. Finally, we created a website, VisualizIRR, for users to interactively explore and visualize the immune repertoires in this study. See related Spotlight by Liu and Han, p. 786.
我们应用计算算法 TRUST4 从癌症基因组图谱和七项免疫疗法研究的大约 12000 个 RNA 测序样本中组装免疫受体(T 细胞受体/B 细胞受体)库。从超过 3500 万个组装的完整互补决定区 3 序列中,我们观察到 CCL5 和 MZB1 的表达分别与 T 细胞克隆扩增和 B 细胞克隆扩增最正相关。我们分析了 B 细胞受体体细胞超突变过程中的氨基酸进化,并确定酪氨酸是首选残基。我们发现 IgG1+IgG3 抗体与 FcRn 一起与补体依赖性细胞毒性和抗体依赖性细胞毒性或吞噬作用相关。除了 B 细胞浸润外,我们还发现 B 细胞克隆扩增和 IgG1+IgG3 抗体也与更好的患者预后相关。最后,我们创建了一个网站 VisualizIRR,供用户交互探索和可视化本研究中的免疫库。见相关的刘和韩的 Spotlight,第 786 页。